Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[This study showed that pathological hypoxia (<0.5% O2) increased the expression of androgen receptor (AR) target genes such as prostate-specific antigen (PSA) and kallikrein-related peptidase 2 in LNCaP human prostate cancer cells by modifying the quantity and activity of related Jumonji C domain-containing histone demethylases (JMJDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[This study showed that pathological hypoxia (<0.5% O2) increased the expression of androgen receptor (AR) target genes such as prostate-specific antigen (PSA) and kallikrein-related peptidase 2 in LNCaP human prostate cancer cells by modifying the quantity and activity of related Jumonji C domain-containing histone demethylases (JMJDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study showed that pathological hypoxia (<0.5% O2) increased the expression of androgen receptor (AR) target genes such as prostate-specific antigen (PSA) and kallikrein-related peptidase 2 in LNCaP human prostate cancer cells by modifying the quantity and activity of related Jumonji C domain-containing histone demethylases (JMJDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study showed that pathological hypoxia (<0.5% O2) increased the expression of androgen receptor (AR) target genes such as prostate-specific antigen (PSA) and kallikrein-related peptidase 2 in LNCaP human prostate cancer cells by modifying the quantity and activity of related Jumonji C domain-containing histone demethylases (JMJDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study showed that pathological hypoxia (<0.5% O2) increased the expression of androgen receptor (AR) target genes such as prostate-specific antigen (PSA) and kallikrein-related peptidase 2 in LNCaP human prostate cancer cells by modifying the quantity and activity of related Jumonji C domain-containing histone demethylases (JMJDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP526395.RAcLGwKCxJCyk-azbXFnri6aXJ5clAUJwj3DsO9aG7Esk130_assertion description "[This study showed that pathological hypoxia (<0.5% O2) increased the expression of androgen receptor (AR) target genes such as prostate-specific antigen (PSA) and kallikrein-related peptidase 2 in LNCaP human prostate cancer cells by modifying the quantity and activity of related Jumonji C domain-containing histone demethylases (JMJDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP526395.RAcLGwKCxJCyk-azbXFnri6aXJ5clAUJwj3DsO9aG7Esk130_provenance.
• assertion description "[This study showed that pathological hypoxia (<0.5% O2) increased the expression of androgen receptor (AR) target genes such as prostate-specific antigen (PSA) and kallikrein-related peptidase 2 in LNCaP human prostate cancer cells by modifying the quantity and activity of related Jumonji C domain-containing histone demethylases (JMJDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study showed that pathological hypoxia (<0.5% O2) increased the expression of androgen receptor (AR) target genes such as prostate-specific antigen (PSA) and kallikrein-related peptidase 2 in LNCaP human prostate cancer cells by modifying the quantity and activity of related Jumonji C domain-containing histone demethylases (JMJDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1096629.RAcIWDebu_gYW9ogJI7Sth8A5uN5UYeqCcnb5dj49Hv2Y130_assertion description "[This study showed that pathological hypoxia (<0.5% O2) increased the expression of androgen receptor (AR) target genes such as prostate-specific antigen (PSA) and kallikrein-related peptidase 2 in LNCaP human prostate cancer cells by modifying the quantity and activity of related Jumonji C domain-containing histone demethylases (JMJDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1096629.RAcIWDebu_gYW9ogJI7Sth8A5uN5UYeqCcnb5dj49Hv2Y130_provenance.
• NP526385.RADwxLJqYfsu1NfS3yT46yiobnjyJICcUhJJZVgkpCcMY130_assertion description "[This study showed that pathological hypoxia (<0.5% O2) increased the expression of androgen receptor (AR) target genes such as prostate-specific antigen (PSA) and kallikrein-related peptidase 2 in LNCaP human prostate cancer cells by modifying the quantity and activity of related Jumonji C domain-containing histone demethylases (JMJDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP526385.RADwxLJqYfsu1NfS3yT46yiobnjyJICcUhJJZVgkpCcMY130_provenance.
• NP247863.RArIuY-YoCGL0c-KprPVqduM1WViJtTCzX_oQzEHHxXAI130_assertion description "[This study showed that pathological hypoxia (<0.5% O2) increased the expression of androgen receptor (AR) target genes such as prostate-specific antigen (PSA) and kallikrein-related peptidase 2 in LNCaP human prostate cancer cells by modifying the quantity and activity of related Jumonji C domain-containing histone demethylases (JMJDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247863.RArIuY-YoCGL0c-KprPVqduM1WViJtTCzX_oQzEHHxXAI130_provenance.
• NP1096627.RAp7jQrqpIzUaGngUV71JQgGfB-3QmeN55t1in1dLnCv4130_assertion description "[This study showed that pathological hypoxia (<0.5% O2) increased the expression of androgen receptor (AR) target genes such as prostate-specific antigen (PSA) and kallikrein-related peptidase 2 in LNCaP human prostate cancer cells by modifying the quantity and activity of related Jumonji C domain-containing histone demethylases (JMJDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1096627.RAp7jQrqpIzUaGngUV71JQgGfB-3QmeN55t1in1dLnCv4130_provenance.
• NP247890.RAMx_01hRbpEW7PiEz6mJnzi4bP4_95OT3HBiPtpjYPgc130_assertion description "[This study showed that pathological hypoxia (<0.5% O2) increased the expression of androgen receptor (AR) target genes such as prostate-specific antigen (PSA) and kallikrein-related peptidase 2 in LNCaP human prostate cancer cells by modifying the quantity and activity of related Jumonji C domain-containing histone demethylases (JMJDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247890.RAMx_01hRbpEW7PiEz6mJnzi4bP4_95OT3HBiPtpjYPgc130_provenance.
• NP1096628.RAJUOWlEjAo2TFx0jdQ0HDYb8n0hBk_v3HlDzYiHB3c3M130_assertion description "[This study showed that pathological hypoxia (<0.5% O2) increased the expression of androgen receptor (AR) target genes such as prostate-specific antigen (PSA) and kallikrein-related peptidase 2 in LNCaP human prostate cancer cells by modifying the quantity and activity of related Jumonji C domain-containing histone demethylases (JMJDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1096628.RAJUOWlEjAo2TFx0jdQ0HDYb8n0hBk_v3HlDzYiHB3c3M130_provenance.
• NP1096630.RAz46pmzDDwNqbplVWb6Nyl00NaiSP_xF5RtPNhPKD7Hg130_assertion description "[This study showed that pathological hypoxia (<0.5% O2) increased the expression of androgen receptor (AR) target genes such as prostate-specific antigen (PSA) and kallikrein-related peptidase 2 in LNCaP human prostate cancer cells by modifying the quantity and activity of related Jumonji C domain-containing histone demethylases (JMJDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1096630.RAz46pmzDDwNqbplVWb6Nyl00NaiSP_xF5RtPNhPKD7Hg130_provenance.
• NP1096631.RA9L3hLI-uXx1nxwa8cyNfKtEpp02PrOzlQ8pMLEBJmuE130_assertion description "[This study showed that pathological hypoxia (<0.5% O2) increased the expression of androgen receptor (AR) target genes such as prostate-specific antigen (PSA) and kallikrein-related peptidase 2 in LNCaP human prostate cancer cells by modifying the quantity and activity of related Jumonji C domain-containing histone demethylases (JMJDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1096631.RA9L3hLI-uXx1nxwa8cyNfKtEpp02PrOzlQ8pMLEBJmuE130_provenance.
• NP1096632.RA2wcOnUdUqFFufSvRPqh7qZcfCXaRi514xYZRf-YQ9iA130_assertion description "[This study showed that pathological hypoxia (<0.5% O2) increased the expression of androgen receptor (AR) target genes such as prostate-specific antigen (PSA) and kallikrein-related peptidase 2 in LNCaP human prostate cancer cells by modifying the quantity and activity of related Jumonji C domain-containing histone demethylases (JMJDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1096632.RA2wcOnUdUqFFufSvRPqh7qZcfCXaRi514xYZRf-YQ9iA130_provenance.